Abstract
Aging is the single largest risk factor for most chronic diseases, and thus possesses large socioeconomic interest to continuously aging societies. Consequently, the field of aging research is expanding alongside a growing focus from the industry and investors in aging research. This year’s 8th Annual Aging Research and Drug Discovery (ARDD) meeting was organized as a hybrid meeting from August 30th to September 3rd 2021 with more than 130 attendees participating on-site at the Ceremonial Hall at University of Copenhagen, Denmark, and 1800 engaging online. The conference comprised of presentations from 75 speakers focusing on new research in topics including mechanisms of aging and how these can be modulated as well as the use of AI and new standards of practices within aging research. This year, a longevity workshop was included to build stronger connections with the clinical community.
| Original language | English |
|---|---|
| Pages (from-to) | 532-543 |
| Number of pages | 12 |
| Journal | Aging |
| Volume | 14 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 28 Jan 2022 |
Bibliographical note
Funding:S.B.J. was supported the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement 863911 - PHYRIST). M.K. was support by NIH grant P30AG013280. S.J.M. and M.R.M. were supported through a research agreement with Zafgen Inc (Boston MA). R.W. Dr is supported by the Novo Nordisk Foundation Challenge Programme: Harnessing the Power of Big Data to Address the Societal Challenge of Aging [NNF17OC0027812]. V.N.G is supported by NIH grants xx. F.C. is supported by the Wellcome Trust/Royal Society (102532/Z/12/Z and 102531/Z/13/A) and MRC (MC-A654-5QC80). L.P. and Y.X.L. are supported by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme no. 741989 and the Max-Planck-Gesellschaft. Y.X.L. is supported by an EMBO Long-Term Fellowship (ALTF 419-2014). C.G.R. is supported by grants from the Swedish Research Council (VR) (2015-03740, 2017-06088, and 2019-04868), the Swedish Cancer Society (Cancerfonden) (20 1034 Pj), the Novo Nordisk Foundation (NNF21OC0070427), and by an ICMC project grant. D.B. is supported by the Lundbeck foundation (#R303-2018-3159). M.S.K. is supported by the Novo Nordisk Foundation Challenge Programme (#NNF17OC0027812), the Nordea Foundation (#02-2017-1749), the Neye Foundation, the Lundbeck Foundation (#R324-2019-1492), the Ministry of Higher Education and Science (#0238-00003B), VitaDAO and Insilico Medicine. We would also like to offer our sincere thanks to our amazing sponsors and all the volunteers that made this meeting possible.
Publisher Copyright:
© 2022, Aging. All rights reserved.